ArticleThe journal of headache and pain2020

A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB.

Giuseppe Tringali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.